SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-14-000589
Filing Date
2014-02-10
Accepted
2014-02-10 15:40:02
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctix_10q.htm 10-Q 1421783
2 CERTIFICATION ctix_ex311.htm EX-31.1 17077
3 CERTIFICATION ctix_ex312.htm EX-31.2 17887
4 CERTIFICATION ctix_ex321.htm EX-32.1 5765
5 CERTIFICATION ctix_ex322.htm EX-32.2 5986
  Complete submission text file 0001477932-14-000589.txt   5618352

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctix-20131231.xml EX-101.INS 535516
7 XBRL TAXONOMY EXTENSION SCHEMA ctix-20131231.xsd EX-101.SCH 64287
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctix-20131231_cal.xml EX-101.CAL 60406
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctix-20131231_def.xml EX-101.DEF 254274
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctix-20131231_lab.xml EX-101.LAB 408733
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctix-20131231_pre.xml EX-101.PRE 308380
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-52321 | Film No.: 14588407
SIC: 2834 Pharmaceutical Preparations